Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
MA02 - RET and Novel Combinations of Osimertinib
- 09:30 - 10:30
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Novel Therapeutics and Targeted Therapies
-
+
MA02.06 - Phase 1b Study of Pelcitoclax (APG-1252) in Combination With Osimertinib in Patients With EGFR TKI-Resistant NSCLC
10:05 - 10:10 | Presenter: Li Zhang
- Abstract
Loading...
-
+
MA03 - Biomarkers for Immunotherapy: Are All Relevant?
- 10:45 - 11:45
- 9/08/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
MA03.05 - DNA Damage Response (DDR) Gene Mutations and Correlation With Immunotherapy Response in NSCLC Patients
11:15 - 11:20 | Presenter: Jiaqing Liu
- Abstract
Loading...
-
+
P17 - Immunotherapy (Phase II/III Trials) - First-Line, Advanced, Squamous NSCLC
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
-
+
P17.01 - KEYNOTE-407 China Extension Final Analysis: Pembrolizumab Plus Chemotherapy for the Treatment of Metastatic Squamous NSCLC
00:00 - 00:00 | Presenter: Ying Cheng
- Abstract
Loading...
-
+
P22 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Monitoring/Prognosis
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
-
+
P22.06 - Prognostic Value of Circulating Tumor Cells in Patients With Small Cell Lung Cancer Receiving Front-Line Treatment
00:00 - 00:00 | Presenter: Haohua Zhu
- Abstract
Loading...
-
+
P24 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Targeted Therapy
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
-
+
P24.02 - Unique Efficacy of Ensartinib on Different ALK Fusion Subtypes Evaluated by Plasma ctDNA
00:00 - 00:00 | Presenter: Tao Wang
- Abstract
Loading...
-
+
P57 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - ICI Biomarkers
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
P57.13 - Correlation of TP53/KMT2C co-mutation and Tumor Microenvironment in Lung Cancer
00:00 - 00:00 | Presenter: Xuhui Zhang
- Abstract
Loading...
-
+
P64 - Small Cell Lung Cancer/ NET - Clinical Trial in Progress
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Small Cell Lung Cancer/ NET
-
+
P64.04 - Hypo-Fractionated Versus Conventionally Fractionated Radiotherapy for Patients with LS-SCLC: An Open-Label, Randomized, Phase 3 Trial
00:00 - 00:00 | Presenter: Nan Bi
- Abstract
Loading...